---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-055657"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T09:42:31.208672+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Outset Medical Q1 revenue $28.2M, net loss $(0.78)/share; CTO departs, $3.0M restructuring

## Summary
- Revenue $28.2M, down 16% YoY; service revenue up 36% to $7.7M, recurring revenue up 24%.
- GAAP net loss $(39.9)M ($(0.78)/share); non-GAAP net loss $(29.3)M ($(0.57)/share).
- Total gross margin improved to 29.2% from 19.2% YoY; product margin 38.4% from 25.1%.
- FY 2024 guidance reaffirmed: revenue $145-153M, non-GAAP gross margin low-30% range.
- CTO Jean-Olivier Racine departs May 17; workforce reduction with $3.0M restructuring charge in Q1.

## SEC filing metadata
- accession: 0000950170-24-055657
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017024055657/0000950170-24-055657-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017024055657/om-20240508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-055657
- JSON: https://secwatch.observer/filing/0000950170-24-055657.json
- Plain text: https://secwatch.observer/filing/0000950170-24-055657.txt

## Key facts
- Earnings Releases
  Outset Medical, Inc. reported first quarter ended March 31, 2024 results: net income $(39.9) million, EPS $(0.78) per share.
  - Period: first quarter ended March 31, 2024
  - Net income: $(39.9) million
  - EPS: $(0.78) per share
  - Result: reported results
  source text: Revenue for the first quarter of 2024 was $28.2 million compared to $33.5 million in the first quarter of 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017024055657/0000950170-24-055657-index.htm
- Earnings Releases
  Outset Medical, Inc. reported first quarter ended March 31, 2024 results: net income $(39.9) million, EPS $(0.78) per share.
  - Period: first quarter ended March 31, 2024
  - Net income: $(39.9) million
  - EPS: $(0.78) per share
  - Result: reported results
  source text: Net loss was $(39.9) million, or $(0.78) per share, compared to net loss of $(44.0) million, or $(0.90) per share, for the same period in 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017024055657/0000950170-24-055657-index.htm
- Earnings Releases
  Outset Medical, Inc. reported full year 2024 results: revenue $145 million to $153 million. Guidance reaffirmed.
  - Period: full year 2024
  - Revenue: $145 million to $153 million
  - Guidance: reaffirmed
  - Result: guidance update
  source text: Outset reaffirmed its previously provided guidance for 2024 including revenue of $145 million to $153 million, growing 12% to 18% over 2023, and non-GAAP gross margin in the low-30% range for the full year 2024, exiting the year in the mid-30% range for the fourth quarter.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017024055657/0000950170-24-055657-index.htm
- Executive change
  Jean-Olivier Racine departed as Chief Technology Officer at Outset Medical, Inc..
  - Action: departed
  - Role: Chief Technology Officer
  source text: Jean-Olivier Racine will depart from his role as the Company's Chief Technology Officer, effective May 17, 2024, in connection with the workforce reduction plan described in Item 8.01 below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017024055657/0000950170-24-055657-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.